ACTIVE

Tools4Patient

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-3,7 M €
-27.7% YoY
Gross margin
-431 k €
-152.2% YoY
Equity
19,5 M €
+12.2% YoY
Workforce
16,2 ETP
0.0% YoY

What does Tools4Patient do?

Tools4Patient is a Public limited company incorporated in 2013. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Mont-Saint-Guibert. It employs on average 16,2 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0534.842.954
Incorporation
31/05/2013
Legal form
Public limited company
Registered office
Rue Granbonpré 11 box 9
1435 Mont-Saint-Guibert · WallonieSee on map
Contributed capital
29 359 852,00 €
Latest accounts
31/12/2025
Average workforce
16,2 ETP
Activities (NACE)
72101Research and experimental development on natural sciences and engineering· main72110Research and experimental development on biotechnology72200Research and experimental development on social sciences and humanities72200Research and experimental development on social sciences and humanities62090Other information technology and computer service activities62900Computer programming, consultancy and related activities+2
Joint committees (1)
  • 200
Signals
Solid equityHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 12 financial years

202520242023202220212020201920182017201620152014
Income statement
Gross margin-431 k €825,5 k €2 M €1,5 M €1,3 M €1,5 M €1 M €715,5 k €566,7 k €628,8 k €507,4 k €565,9 k €
EBITDA-2,5 M €-1,7 M €189,5 k €-331,1 k €-295,4 k €43,5 k €-310,4 k €-274,2 k €-195,6 k €10,2 k €6,5 k €559,1 €
Operating result-3,8 M €-2,9 M €-730,5 k €-1,2 M €-1,2 M €2,5 k €-441,7 k €-274,2 k €-195,6 k €10,2 k €6,5 k €559,1 €
Net result-3,7 M €-2,9 M €-1,1 M €-1,2 M €-1,3 M €-160,9 k €-519 k €-320,4 k €-229 k €–––
Balance sheet
Equity19,5 M €17,4 M €10,7 M €11,9 M €13,2 M €10,3 M €10,4 M €6,8 M €3,7 M €3,5 M €2,6 M €1,4 M €
Total assets23,1 M €22 M €20,7 M €19,1 M €18,1 M €16,4 M €12,8 M €10 M €6,6 M €4,3 M €3,6 M €1,7 M €
Cash622,5 k €491,6 k €122,4 €18,6 k €574,2 k €1,1 M €353,6 k €755,2 k €348,7 k €125,2 k €653,6 k €335,7 k €
Debts3,6 M €4,5 M €10 M €7,2 M €4,8 M €5,8 M €2,3 M €3,1 M €2,3 M €671,5 k €755,9 k €158,3 k €
Other
Workforce16,2 ETP16,2 ETP15,7 ETP16,1 ETP17,1 ETP17,7 ETP13,9 ETP11,2 ETP8,9 ETP6,6 ETP6,0 ETP5,0 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active · 28 ended

Active mandates

EDITH COUNE

Director · since 08 avril 2024

Active
OLIVIER HOUBEN

Director · since 08 avril 2024

Active
SPARAXIS

Director · since 08 avril 2024 · 0452.116.307

Represented by SOPHIE SAUVAGE

Active
YVES VANDEKERCKHOVE

Director · since 22 février 2018

Active
NOVICREO

Managing director · since 29 mai 2013 · 0885.428.866

Represented by DOMINIQUE DEMOLLE

Active

Ended mandates

CHRISTIAN JOURQUIN

Director · since 13 décembre 2021 · until 08 avril 2024

Ended
CHRISTIAN JOURQUIN

Director · since 13 décembre 2021

Ended
FONDS DE CAPITAL A RISQUE 2020

Director · since 18 juin 2019 · 0667.964.566

Represented by HELENA POZIOS

Ended
FONDS DE CAPITAL A RISQUE 2020

Director · since 18 juin 2019 · until 15 décembre 2021 · 0667.964.566

Represented by HELENA POZIOS

Ended
At this address

Other companies at this address

CompanyCBE no.
Ascend Performance Materials● Active
0810.113.316
Ascend Performance Materials Belgium Holdco● Active
1012.379.397
AUDANE INVEST● Active
0816.921.429
BiocSol● Active
1003.683.546
CEDRIC CLAERHOUDT● Active
0477.799.927
Cellaïon● Liquidation
0764.522.425
Clinigen Clinical Supplies Management● Active
0859.906.087
Cronos Sud● Active
1014.190.824
DE SMET AGRO● Active
0402.951.757
DE SMET S.A. - ENGINEERS & CONTRACTORS● Active
0438.987.752
FLEXSO BRUSSELS● Active
0898.889.892
Keiro● Active
0681.490.821
NOVADIP BIOSCIENCES● Active
0535.575.602
PARLYM BELGIUM● Active
1028.144.372
PARSMET MANAGEMENT● Active
1025.167.858
PROMETHERA BIOSCIENCES● Bankrupt
0809.788.365
TFP IMMO● Active
1032.940.330
The Akkermansia Company● Active
0664.529.083
THE TORREFACTORY PROJECT● Active
0679.686.720
VAT Group Ascend● Active
1002.911.308
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date22/06/202607/07/202526/07/202402/08/202328/07/202207/10/2021
General meeting16/06/202617/06/202525/06/202420/06/202312/07/202215/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

13 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202516/06/202622/06/2026FrenchPDF
Abridged model31/12/202417/06/202507/07/2025FrenchPDF
Abridged model31/12/202325/06/202426/07/2024FrenchPDF
Abridged model31/12/202220/06/202302/08/2023FrenchPDF
Abridged model31/12/202112/07/202228/07/2022FrenchPDF
Abridged modelCorrection31/12/202015/06/202107/10/2021FrenchPDF
Abridged model31/12/202015/06/202103/08/2021FrenchPDF
Abridged model31/12/201903/09/202004/09/2020FrenchPDF
Abridged model31/12/201818/06/201925/06/2019FrenchPDF
Abridged model31/12/201719/06/201821/06/2018FrenchPDF
Abridged model31/12/201613/06/201704/07/2017FrenchPDF
Abridged model31/12/201521/06/201601/08/2016FrenchPDF
Abridged model31/12/201416/06/201526/07/2015FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active · 28 ended

Active mandates

EDITH COUNE

Director · since 08 avril 2024

Active
OLIVIER HOUBEN

Director · since 08 avril 2024

Active
SPARAXIS

Director · since 08 avril 2024 · 0452.116.307

Represented by SOPHIE SAUVAGE

Active
YVES VANDEKERCKHOVE

Director · since 22 février 2018

Active
NOVICREO

Managing director · since 29 mai 2013 · 0885.428.866

Represented by DOMINIQUE DEMOLLE

Active

Ended mandates

CHRISTIAN JOURQUIN

Director · since 13 décembre 2021 · until 08 avril 2024

Ended
CHRISTIAN JOURQUIN

Director · since 13 décembre 2021

Ended
FONDS DE CAPITAL A RISQUE 2020

Director · since 18 juin 2019 · 0667.964.566

Represented by HELENA POZIOS

Ended
FONDS DE CAPITAL A RISQUE 2020

Director · since 18 juin 2019 · until 15 décembre 2021 · 0667.964.566

Represented by HELENA POZIOS

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Capital / shares23/01/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Other23/12/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates03/07/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates11/04/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates23/02/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates28/12/2021
    SIEGE SOCIAL - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates19/10/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates18/12/2019
    DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-3,7 M €↓
  2. 2024
    Annual accounts 2024-2,9 M €↓
  3. 2023
    Annual accounts 2023-1,1 M €↑
  4. 2022
    Annual accounts 2022-1,2 M €↑
  5. 2021
    Annual accounts 2021-1,3 M €↓
  6. 2020
    Annual accounts 2020-160,9 k €↑
  7. 2019
    Annual accounts 2019-519 k €↓
  8. 2018
    Annual accounts 2018-320,4 k €↓
  9. 2017
    Annual accounts 2017-229 k €
  10. 2016
    Annual accounts 2016
  11. 2015
    Annual accounts 2015
  12. 2014
    Annual accounts 2014
  13. 31/05/2013
    IncorporationPublic limited company